Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/10/2026

1. CSQR
2. B
3. STDN
4. SPY
5. TTWO
6. NTHI
7. RHP
8. SLN
9. SION
10. ACH

Go back to Invivyd Announces Completion of Enrollment in Phase 3 LIBERTY Trial Evaluating VYD2311 Antibody Versus mRNA COVID-19 Vaccine
(NASDAQ: IVVD) Delayed: 0.70 -0.04 (5.41%)
Previous Close $0.74    52 Week High $ 
Open $0.74    52 Week Low $ 
Day High $0.75    P/E N/A 
Day Low $0.68    EPS $ 
Volume 1,418,789       

(NASDAQ: IVVD) Delayed: 0.70 -0.04 (5.41%)
Previous Close $0.74    52 Week High $ 
Open $0.74    52 Week Low $ 
Day High $0.75    P/E N/A 
Day Low $0.68    EPS $ 
Volume 1,418,789